The University Hospitals Harrington Heart & Vascular Institute has launched a program for noninvasive stereotactic body radiation therapy to treat refractory ventricular tachycardia.
The medical center is one of a select few across the world that provides SBRT for VT. The treatment uses radiation to neutralize damaged heart tissue that causes VT, according to an April 14 news release from University Hospitals.
SBRT can be completed in about 40 minutes compared to a standard catheter ablation that can take four to six hours. The treatment can be performed in patients who have blood clots that make traditional procedures risky.
VT is a leading cause of sudden cardiac arrest in the U.S.
The therapy is currently reserved for compassionate use, but indications and clinical applications are expected to increase over the next few years, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
